Salem Investment Counselors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-145
| Closed | -$14K | – | 1177 |
|
|
2023
Q4 | $14K | Hold |
145
| – | – | ﹤0.01% | 755 |
|
|
2023
Q3 | $12.8K | Hold |
145
| – | – | ﹤0.01% | 757 |
|
|
2023
Q2 | $12.6K | Hold |
145
| – | – | ﹤0.01% | 787 |
|
|
2023
Q1 | $14.1K | Hold |
145
| – | – | ﹤0.01% | 757 |
|
|
2022
Q4 | $15K | Hold |
145
| – | – | ﹤0.01% | 707 |
|
|
2022
Q3 | $12K | Hold |
145
| – | – | ﹤0.01% | 715 |
|
|
2022
Q2 | $12K | Hold |
145
| – | – | ﹤0.01% | 749 |
|
|
2022
Q1 | $11K | Hold |
145
| – | – | ﹤0.01% | 737 |
|
|
2021
Q4 | $13K | Hold |
145
| – | – | ﹤0.01% | 784 |
|
|
2021
Q3 | $11K | Hold |
145
| – | – | ﹤0.01% | 737 |
|
|
2021
Q2 | $12K | Hold |
145
| – | – | ﹤0.01% | 688 |
|
|
2021
Q1 | $11K | Buy |
+145
| New | +$11K | ﹤0.01% | 661 |
|